258 related articles for article (PubMed ID: 17034997)
21. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
[TBL] [Abstract][Full Text] [Related]
22. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
[TBL] [Abstract][Full Text] [Related]
23. Modification of pancreatic carcinogenesis in the hamster model. XV. Preventive effect of nicotinamide.
Pour PM; Lawson T
J Natl Cancer Inst; 1984 Sep; 73(3):767-70. PubMed ID: 6236323
[TBL] [Abstract][Full Text] [Related]
24. Mutations of LKB1 gene in pancreatic ductal adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.
Furukawa M; Yamasaki A; Yoshida J; Tsujino M; Wakabayashi N; Honoki K; Tsujiuchi T
Anticancer Res; 2009 Oct; 29(10):4047-50. PubMed ID: 19846949
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
Zervos EE; Norman JG; Gower WR; Franz MG; Rosemurgy AS
J Surg Res; 1997 May; 69(2):367-71. PubMed ID: 9224409
[TBL] [Abstract][Full Text] [Related]
27. The impact of laparoscopic biopsy of pancreatic lymph nodes with helium and carbon dioxide on port site and liver metastasis in BOP-induced pancreatic cancer in hamster.
Wenger FA; Jacobi CA; Kilian M; Dressler H; Guski H; Müller JM
Clin Exp Metastasis; 2000; 18(1):11-4. PubMed ID: 11206832
[TBL] [Abstract][Full Text] [Related]
28. Modification of pancreatic carcinogenesis in the hamster model. IX. Effect of pancreatitis.
Pour PM; Takahashi M; Donnelly T; Stepan K
J Natl Cancer Inst; 1983 Sep; 71(3):607-13. PubMed ID: 6577234
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.
Kapischke M; Fischer T; Tiessen K; Tschesche H; Bruch HP; Kalthoff H; Kruse ML
Int J Oncol; 2008 Jan; 32(1):273-82. PubMed ID: 18097568
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
[TBL] [Abstract][Full Text] [Related]
31. Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.
Jung K; Krell HW; Ortel B; Hasan T; Römer A; Schnorr D; Loening SA; Lein M
Prostate; 2003 Feb; 54(3):206-11. PubMed ID: 12518325
[TBL] [Abstract][Full Text] [Related]
32. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
Juuti A; Lundin J; Nordling S; Louhimo J; Haglund C
Oncology; 2006; 71(1-2):61-8. PubMed ID: 17377415
[TBL] [Abstract][Full Text] [Related]
33. Influence of octreotide on liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters.
Wenger FA; Kilian M; Mautsch I; Jacobi CA; Steiert A; Peter FJ; Guski H; Schimke I; Müller JM
Pancreas; 2001 Oct; 23(3):266-72. PubMed ID: 11590322
[TBL] [Abstract][Full Text] [Related]
34. The role of pancreatic islets in experimental pancreatic carcinogenicity.
Ishikawa O; Ohigashi H; Imaoka S; Nakai I; Mitsuo M; Weide L; Pour PM
Am J Pathol; 1995 Nov; 147(5):1456-64. PubMed ID: 7485408
[TBL] [Abstract][Full Text] [Related]
35. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
[TBL] [Abstract][Full Text] [Related]
36. Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.
Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Tsuneoka N; Kanematsu T
Carcinogenesis; 2008 Apr; 29(4):830-3. PubMed ID: 18296437
[TBL] [Abstract][Full Text] [Related]
37. Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer.
Wenger FA; Kilian M; Braumann C; Neumann A; Ridders J; Peter FJ; Guski H; Jacobi CA
Clin Exp Metastasis; 2002; 19(2):169-73. PubMed ID: 11964081
[TBL] [Abstract][Full Text] [Related]
38. Does dietary alpha-linolenic acid promote liver metastases in pancreatic carcinoma initiated by BOP in Syrian hamster?
Wenger FA; Jacobi CA; Kilian M; Zieren J; Zieren HU; Müller JM
Ann Nutr Metab; 1999; 43(2):121-6. PubMed ID: 10436311
[TBL] [Abstract][Full Text] [Related]
39. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.
Lorenzl S; Narr S; Angele B; Krell HW; Gregorio J; Kiaei M; Pfister HW; Beal MF
Exp Neurol; 2006 Jul; 200(1):166-71. PubMed ID: 16516196
[TBL] [Abstract][Full Text] [Related]
40. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
Krüger A; Arlt MJ; Gerg M; Kopitz C; Bernardo MM; Chang M; Mobashery S; Fridman R
Cancer Res; 2005 May; 65(9):3523-6. PubMed ID: 15867341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
